{"id":"W2752873349","doi":"10.1200/jco.2013.31.15_suppl.5518","title":"Targeting p53 mutant ovarian cancer: Phase I results of the WEE1 inhibitor MK-1775 with carboplatin plus paclitaxel in patients (pts) with platinum-sensitive, p53-mutant ovarian cancer (OC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Carboplatin; Febrile neutropenia; Tolerability; Oncology; Adverse effect; Cancer; Phases of clinical research; Taxane; Gastroenterology; Chemotherapy; Cisplatin; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090819,0.001235148,0.00157707,0.0004627224,0.0002979255,0.0007110569,0.0006407339,0.001119212,0.001941728],"category_scores_gemma":[0.0008501869,0.0005401191,0.001258251,0.000431995,0.0006351798,0.0006435954,0.0003228268,0.001730395,0.0004797605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001122925,"about_ca_system_score_gemma":0.001226669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00141441,"about_ca_topic_score_gemma":0.003215451,"domain_scores_codex":[0.9996831,0.0001438381,0.0000296141,0.00004027445,0.00003356976,0.00006965613],"domain_scores_gemma":[0.9995421,0.0000654269,0.00009495819,0.00003474796,0.0000248776,0.00023785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7147539,0.08232213,0.01547016,0.001528139,0.001952801,0.0006136438,0.0006057149,0.004089272,0.05418102,0.0003312828,0.003095762,0.1210561],"study_design_scores_gemma":[0.356333,0.6063114,0.02351167,0.00007085509,0.001054892,0.0005587074,0.00009012378,0.001027813,0.007694945,0.0001382391,0.003176458,0.00003193336],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936262,0.002055689,0.0002501953,0.0002863162,0.00006469867,0.002288634,0.0005625129,0.00003077708,0.0008349303],"genre_scores_gemma":[0.9903179,0.00260728,0.001262286,0.0005865925,0.0001231413,0.001778995,0.0015449,0.00001279565,0.001766041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001941728,"threshold_uncertainty_score":0.008147418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02880463901628139,"score_gpt":0.3556495586213135,"score_spread":0.3268449196050321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}